In an exclusive statement released through Guggenheim Securities, LLC, former Pfizer CEO Ian Read and former CFO Frank D’Amelio addressed growing s...
In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...
Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...
May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care providers about hepatitis vaccinations. Hepatitis is an inf...
In an interview with BioPharma BoardRoom, Cem Zorlular, CEO of Er-Kim, shares his personal journey and the driving force behind Er-Kim's mission to...
In an interview with BioPharma BoardRoom, Eric Blair, GDMC’s Chief Business Officer, discusses the company's strategic use of Series A funding to pio...
Cold Spring Harbor Laboratory (CSHL) Professor Christopher Hammell has found that in the worm C. elegans, this genetic orchestra has no single conduct...
In the fast-paced realm of drug discovery, Molecule GEN stands as a beacon of innovation, promising a quantum leap in the way we approach pharmaceutical br...
In a rapidly evolving world where scientific breakthroughs are essential for the betterment of healthcare, MoleculeAI stands at the forefront, pioneering t...
“Agilent is committed to our customers’ success at every stage of their journey to bring great science to life,” said Agilent President a...
What if there was a solution? A golden key or antidote to lift the fog and restore your mind? How far would you go to obtain it? And if it doesn't ...
Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...
In a highly anticipated conversation with BioPharma BoardRoom, Eric Hsu, Director of Key Account Management at Samsung Biologics, shares groundbreaking ins...
Largely driven by increasing incidence of chronic and infectious diseases and growth in biotechnology and pharma industries, the global immunoassay market ...
© 2024 Biopharma Boardroom. All Rights Reserved.
